NAMS
NewAmsterdam Pharma Company N.V.
NASDAQ · NLHealthcareBiotechnology
$29.67-6.34%
Price as of Jul 20, 2026
NAMS capital
NewAmsterdam Pharma Company N.V. capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- 0.00x
- Net debt / equity
- -0.69x
- Debt / assets
- 0.00x
- Debt / EBITDA
- -0.00x
- Net debt / EBITDA
- 2.15x
Liquidity & coverage
- Current ratio
- 9.76x
- Quick ratio
- 9.76x
- Cash ratio
- 9.43x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $590.6M
Cash & dividend
- FCF / debt
- -6182.04x
- Cash flow / debt
- -6170.39x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.